Treatment For Itching With Redness

PHARMACO-THERAPEUTIC STUDY OF MIRCHIYAKANDADI GUDAPAK (KALPIT YOG) IN THE MANAGEMENT OF SHEETAPITTA W.S.R. TO URTICARIA

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016582

Enrollment

Registered

2018-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R21- Rash and other nonspecific skin eruption

Interventions

Intervention1: Mirchiyakandadi Gudapak: Group-A Mirchiyakandadi Gudapak, 1 karsh (12 gm) BD after meal with lukewarm water for 30 days. Control Intervention1: Haridrakhand: Group-B Haridrakhand, 5gm t

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical symptoms of Sheetapitta Mandala (rashes), Kandu (severe itching), Toda (pricking pain), Daha (burning) are included in our study.

Exclusion criteria

Exclusion criteria: 1. Drugs induced Urticaria. 2. Patients having history of any chronic diseases.eg Heart Diseases, Paraplegia. 3. Patients below the age of 16 years and above 60 years.

Design outcomes

Primary

Measure	Time frame
To Evaluate Pharmacological And Therapeutic Efficacy Of Drug MIRCHIYAKANDADI GUDAPAKTimepoint: 30 Days	—

Secondary

Measure	Time frame
To evaluate Pharmacological Efficacy Of Drug For Long TimeTimepoint: Long Time	—

Countries

India

Contacts

Public ContactMeenakshi Kumawat

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

chandan_singh4@yahoo.com9950156020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026